Skip to content

Yi-Qi Liang-Xue Sheng-Ji party in the prevention and treatment of cardiavascular events of post-intervention of coronary heart disease (CHD): prospective, multicenter, randomized, double-blind, parallel placebo controlled trial

Yi-Qi Liang-Xue Sheng-Ji party in the prevention and treatment of cardiavascular events of post-intervention of coronary heart disease (CHD): prospective, multicenter, randomized, double-blind, parallel placebo controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003081
Enrollment
Unknown
Registered
2020-03-05
Start date
2020-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Sponsors

Oriental Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) in accordance with the western medicine of coronary heart disease diagnosis standard, PCI in patients with indications; (2) comply with the PCI success standard patients; (3) in accordance with the traditional Chinese medicine qi deficiency and blood stasis and dampness and heat exchange by patients; (4) aged 30 ~ 80 years old; (5) informed consent, voluntary subjects and signed informed consent

Exclusion criteria

Exclusion criteria: (1) the PCI acute complications; (2) with liver, kidney and hematopoietic system, severe primary disease or mental illness; (3) malignant tumor; (4) with type 1 diabetes; (5) uncontrolled severe hypertension; (6) correlation of severe infection disease; (7) for nearly two weeks using traditional Chinese medicine (including proprietary Chinese medicine), or to participate in other clinical trials of patients.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiac even;Drug omics and metabonomics detection;quality of life scale;ECG;Angina score scale;response rate;Gensini score;TCM syndrome integral;Seattle Angina Questionnaire;

Countries

China

Contacts

Public ContactWan Jie

Beijing University of Chinese Medicine

yuezhijie1226@sina.com+86 13811268632

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026